DEVEN FETZEK: Open Payments
NPI 1326290511 · PRINCE FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 24 payments from 8 companies in 2025. Trend: 2023 $217 · 2024 $722 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 8 | $142 |
| ABBVIE INC. | 3 | $60 |
| Novartis Pharmaceuticals Corporation | 2 | $54 |
| Organon LLC | 4 | $52 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| Lilly USA, LLC | 2 | $44 |
| Janssen Biotech, Inc. | 1 | $35 |
| Incyte Corporation | 1 | $28 |
Products named: DAXXIFY, SKYRIZI, Sotyktu, TALTZ, VTAMA, TREMFYA, OPZELURA, Rhapsido.
Industry payments across MD — which companies pay providers there.
